 |
PDBsum entry 2a97
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.3.4.24.69
- bontoxilysin.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
Limited hydrolysis of proteins of the neuroexocytosis apparatus, synaptobrevins, SNAP25 or syntaxin. No detected action on small molecule substrates.
|
 |
 |
 |
 |
 |
Cofactor:
|
 |
Zn(2+)
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
DOI no:
|
Biochemistry
44:11758-11765
(2005)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structural analysis of botulinum neurotoxin serotype F light chain: implications on substrate binding and inhibitor design.
|
|
R.Agarwal,
T.Binz,
S.Swaminathan.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The seven serologically distinct Clostridium botulinum neurotoxins (BoNTs A-G)
are zinc endopeptidases which block the neurotransmitter release by cleaving one
of the three proteins of the soluble N-ethylmaleimide-sensitive-factor
attachment protein receptor complex (SNARE complex) essential for the fusion of
vesicles containing neurotransmitters with target membranes. These
metallopeptidases exhibit unique specificity for the substrates and peptide
bonds they cleave. Development of countermeasures and therapeutics for BoNTs is
a priority because of their extreme toxicity and potential misuse as biowarfare
agents. Though they share sequence homology and structural similarity, the
structural information on each one of them is required to understand the
mechanism of action of all of them because of their specificity. Unraveling the
mechanism will help in the ultimate goal of developing inhibitors as
antibotulinum drugs for the toxins. Here, we report the high-resolution
structure of active BoNT/F catalytic domain in two crystal forms. The structure
was exploited for modeling the substrate binding and identifying the S1' subsite
and the putative exosites which are different from BoNT/A or BoNT/B. The
orientation of docking of the substrate at the active site is consistent with
the experimental BoNT/A-LC:SNAP-25 peptide model and our proposed model for
BoNT/E-LC:SNAP-25.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
G.Masuyer,
M.Beard,
V.A.Cadd,
J.A.Chaddock,
and
K.R.Acharya
(2011).
Structure and activity of a functional derivative of Clostridium botulinum neurotoxin B.
|
| |
J Struct Biol,
174,
52-57.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
M.Montal
(2010).
Botulinum neurotoxin: a marvel of protein design.
|
| |
Annu Rev Biochem,
79,
591-617.
|
 |
|
|
|
|
 |
Y.Fujinaga
(2010).
Interaction of botulinum toxin with the epithelial barrier.
|
| |
J Biomed Biotechnol,
2010,
974943.
|
 |
|
|
|
|
 |
A.Fischer,
Y.Nakai,
L.M.Eubanks,
C.M.Clancy,
W.H.Tepp,
S.Pellett,
T.J.Dickerson,
E.A.Johnson,
K.D.Janda,
and
M.Montal
(2009).
Bimodal modulation of the botulinum neurotoxin protein-conducting channel.
|
| |
Proc Natl Acad Sci U S A,
106,
1330-1335.
|
 |
|
|
|
|
 |
M.C.Scotcher,
J.A.McGarvey,
E.A.Johnson,
and
L.H.Stanker
(2009).
Epitope characterization and variable region sequence of f1-40, a high-affinity monoclonal antibody to botulinum neurotoxin type a (Hall strain).
|
| |
PLoS ONE,
4,
e4924.
|
 |
|
|
|
|
 |
M.Montal
(2009).
Translocation of botulinum neurotoxin light chain protease by the heavy chain protein-conducting channel.
|
| |
Toxicon,
54,
565-569.
|
 |
|
|
|
|
 |
R.Agarwal,
J.J.Schmidt,
R.G.Stafford,
and
S.Swaminathan
(2009).
Mode of VAMP substrate recognition and inhibition of Clostridium botulinum neurotoxin F.
|
| |
Nat Struct Mol Biol,
16,
789-794.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
A.Fischer,
C.Garcia-Rodriguez,
I.Geren,
J.Lou,
J.D.Marks,
T.Nakagawa,
and
M.Montal
(2008).
Molecular architecture of botulinum neurotoxin E revealed by single particle electron microscopy.
|
| |
J Biol Chem,
283,
3997-4003.
|
 |
|
|
|
|
 |
B.R.Eapen
(2008).
Molecular biology of botulinum neurotoxin serotype A: a cosmetic perspective.
|
| |
J Cosmet Dermatol,
7,
221-225.
|
 |
|
|
|
|
 |
D.Kumaran,
R.Rawat,
M.L.Ludivico,
S.A.Ahmed,
and
S.Swaminathan
(2008).
Structure- and substrate-based inhibitor design for Clostridium botulinum neurotoxin serotype A.
|
| |
J Biol Chem,
283,
18883-18891.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
R.Agarwal,
and
S.Swaminathan
(2008).
SNAP-25 substrate peptide (residues 180-183) binds to but bypasses cleavage by catalytically active Clostridium botulinum neurotoxin E.
|
| |
J Biol Chem,
283,
25944-25951.
|
 |
|
PDB code:
|
 |
|
|
|
|
|
 |
S.A.Ahmed,
M.A.Olson,
M.L.Ludivico,
J.Gilsdorf,
and
L.A.Smith
(2008).
Identification of residues surrounding the active site of type A botulinum neurotoxin important for substrate recognition and catalytic activity.
|
| |
Protein J,
27,
151-162.
|
 |
|
|
|
|
 |
A.Fischer,
and
M.Montal
(2007).
Crucial role of the disulfide bridge between botulinum neurotoxin light and heavy chains in protease translocation across membranes.
|
| |
J Biol Chem,
282,
29604-29611.
|
 |
|
|
|
|
 |
A.T.Brunger,
M.A.Breidenbach,
R.Jin,
A.Fischer,
J.S.Santos,
and
M.Montal
(2007).
Botulinum neurotoxin heavy chain belt as an intramolecular chaperone for the light chain.
|
| |
PLoS Pathog,
3,
1191-1194.
|
 |
|
|
|
|
 |
N.R.Silvaggi,
G.E.Boldt,
M.S.Hixon,
J.P.Kennedy,
S.Tzipori,
K.D.Janda,
and
K.N.Allen
(2007).
Structures of Clostridium botulinum Neurotoxin Serotype A Light Chain complexed with small-molecule inhibitors highlight active-site flexibility.
|
| |
Chem Biol,
14,
533-542.
|
 |
|
PDB codes:
|
 |
|
|
|
|
|
 |
S.Chen,
J.J.Kim,
and
J.T.Barbieri
(2007).
Mechanism of substrate recognition by botulinum neurotoxin serotype A.
|
| |
J Biol Chem,
282,
9621-9627.
|
 |
|
|
|
|
 |
P.R.Mittl,
and
M.G.Grütter
(2006).
Opportunities for structure-based design of protease-directed drugs.
|
| |
Curr Opin Struct Biol,
16,
769-775.
|
 |
|
|
|
|
 |
S.Chen,
and
J.T.Barbieri
(2006).
Unique substrate recognition by botulinum neurotoxins serotypes A and E.
|
| |
J Biol Chem,
281,
10906-10911.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
Where a reference describes a PDB structure, the PDB
code is
shown on the right.
|
');
}
}
 |